ANG Lifesciences India Limited IPO
ANG Lifesciences India Limited is a pharmaceutical company whose engaged in the business of manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials in India.
Company’s products include sterile dry powder vials for anti-biotics, anti-ulcerant, glucocorticoid and anti-inflammatory, anti-malarial, and anaesthetic. It manufactures products in compliance with GMP requirements.
However, Company that currently operates at an average capacity utilization of 70% for last two fiscals hopes to achieve 90% plus in coming years. ANGL is likely to consider acquisition options as well to enhance its manufacturing capacities. Its customer list includes Wockhardt, DHS Maharashtra, Global Hospitals, Elder, Emcure, BPPI, Govt. of Haryana, Hetero Healthcare etc.
Objects of the ANG Lifesciences India Limited IPO:
ANG Lifesciences India Limited IPO Details:
|Open Date:||Aug 29 2017|
|Close Date:||Aug 31 2017|
|Face Value:||₹ 10 Per Equity Share|
|Issue Type:||Fixed Price Issue IPO|
|Issue Size:||12.01 Cr.|
|Lot Size:||1600 Shares|
|Issue Price:||₹ 80 Per Equity Share|
|Listing At:||BSE SME|
|Listing Date:||Sep 08 2017|